Tuberculosis is still affecting millions of people worldwide, and new resistant strains of Mycobacterium tuberculosis are being found. It is therefore necessary to find new compounds for treatment. In this paper, we report the synthesis and in vitro testing of peptidyl β-aminoboronic acids and β-aminoboronates with anti-tubercular activity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/psc.2537 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!